Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, fatigue is a recognised side effect of the semaglutide injection. Clinical trial data and NHS medicines guidance both confirm that tiredness can occur, particularly in the early weeks of treatment or after a dose increase. It is usually mild, tends to settle as the body adjusts, and does not affect everyone to the same degree. That said, understanding why it happens — and what to watch for — makes a real difference to how you manage it. Semaglutide (sold as Wegovy for weight management) is a prescription-only medicine; a GPhC-registered prescriber assesses whether it is suitable for you before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
In the STEP 1 trial (the pivotal 68-week study of semaglutide 2.4 mg published in the New England Journal of Medicine) fatigue and headache were among the adverse events reported more frequently in the active-treatment group than in the placebo group. The pattern tracked the dose-escalation schedule: symptoms clustered in the first four weeks at each new strength, then typically faded. This mirrors what NHS semaglutide guidance describes when it lists tiredness alongside nausea, dizziness and headache as common effects.
The mechanism is not a single thing. Semaglutide slows gastric emptying and reduces appetite sharply. Many people eat considerably less in the first weeks (sometimes without fully realising it) and that calorie reduction on its own can cause tiredness. There is also a modest lowering of blood-glucose levels after meals, and even small fluctuations can leave people feeling flat. If you want a detailed explanation of why this happens, our page on whether taking semaglutide makes you tired walks through the physiology behind these energy dips. The gut-brain signalling changes that drive satiety are real and felt throughout the body, not just in the stomach.
One detail worth knowing: tiredness tends to peak around the same time as nausea, roughly in the 24–72 hours after an injection, and then improve. If you can, timing your dose for a quieter patch of the week helps. Some people find a Friday or Saturday injection means any grogginess sits across a weekend rather than a working Monday.
Not everyone experiences fatigue. A few things appear to influence whether you do. People who enter treatment already eating very little relative to their activity level may find the appetite suppression tips them into an energy deficit faster. Those with a history of low blood pressure or who are cutting out sugary foods at the same time may also notice more tiredness in the early weeks.
Dehydration is an underappreciated factor. Nausea can put people off drinking fluids, and even mild dehydration causes fatigue. Keeping fluid intake steady (small sips across the day if larger drinks feel difficult) matters more than it might seem. Adequate protein intake is another lever; on a reduced appetite it is easy to drop protein below the level needed to maintain energy and muscle.
The dose level plays a role too. The titration schedule for Wegovy starts at a low dose and increases gradually for this reason, it gives the body time to adapt. Tiredness that is manageable at one dose may prompt a conversation with a prescriber about slowing the escalation rather than stopping treatment entirely. That conversation is exactly what prescriber support is for, and it is worth raising rather than pushing through and feeling miserable. For broader context on the Wegovy side-effect profile, the full side effects overview covers the range of common and less common effects.
Most fatigue linked to the semaglutide shot is mild and self-limiting. There are situations, though, where tiredness signals something that needs prompt clinical review rather than simple reassurance.
Severe, worsening fatigue alongside persistent stomach pain (particularly pain that radiates to the back) should not be managed at home. The MHRA has highlighted acute pancreatitis as a known, if infrequent, serious side effect of GLP-1 medicines; that combination of symptoms warrants same-day medical advice. Similarly, if tiredness accompanies signs of significant dehydration (very dark urine, dizziness on standing, inability to keep fluids down for more than a day), contact a clinician or call NHS 111. You can report suspected side effects directly through the MHRA Yellow Card scheme.
Fatigue that does not ease after two to three weeks at a stable dose, or that seems to be worsening rather than improving, is also worth raising. It may simply reflect the body still adjusting, but it is the kind of question our prescribers handle regularly, it is far better asked than ignored. If you are already on treatment and want to discuss how you are feeling, the contact page connects you to aftercare support seven days a week.
Anyone wondering more broadly about tiredness patterns across different semaglutide doses and presentations will find the semaglutide and tiredness resource useful for additional context. And if you are earlier in your decision-making and still weighing up the full picture of whether Wegovy makes you tired, that page works through the same question from a slightly different angle. The semaglutide sick day rules page is also worth reading if nausea and fatigue arrive together and you are unsure when to pause a dose.
Semaglutide is a prescription-only medicine. If you have not yet started treatment and are wondering whether the side-effect profile is manageable for you, a prescriber is the right person to work through that with. Check your eligibility with a free consultation, it costs nothing and the review is done by a qualified clinician the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.